Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/310158/000119312519067302/d720057d8k.htm
February 2023
October 2022
July 2022
May 2022
April 2022
April 2022
March 2022
February 2022
December 2021
October 2021
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/310158/000119312519067302/d720057d8k.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Merck Co., Inc..
Merck Co., Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:
Material Contracts, Statements, Certifications & more
Merck Co., Inc. provided additional information to their SEC Filing as exhibits
Ticker: MRKEvents:
CIK: 310158
Form Type: 8-K Corporate News
Accession Number: 0001193125-19-067302
Submitted to the SEC: Thu Mar 07 2019 4:35:32 PM EST
Accepted by the SEC: Thu Mar 07 2019
Period: Thursday, March 7, 2019
Industry: Pharmaceutical Preparations